Page 15 - Market Trends

Pfizer soars 8%; Sun, Lupin gain up to 4%; here's what triggered the rally

Pfizer-US trade deal triggers rally in pharma stocks. Nifty Pharma and BSE Healthcare index jumped 1 per cent each; while Nifty 50 and BSE Sensex advanced 0.1 per cent each in Wednesday's early trade.

Lumax Industries zooms 137% in 8 months; smallcap stock trades at new high

Lumax Industries Share: This smallcap stock was trading higher for the sixth straight day, surging 18 per cent during the period.

Ola Electric freezes at 5% upper circuit after 24% fall from September high

Ola Electric up 5% on heavy volumes; till 12:49 PM, a combined 18.36 million equity shares changed hands and there were pending buy orders for 812,000 equity shares on the NSE and BSE.

Tata Investment shares up for 3rd day on heavy volumes, zoom 32% in 6 days

Shares of Tata Investment Corporation hit a new high of ₹9,596.75, surging 9 per cent on the BSE in Tuesday's intra-day trade in an otherwise subdued market.

Gold hits new high, Silver ₹1.5 lakh; how to trade Titan, jewellery stocks?

Technical charts suggest that shares of gold loan firms, which have surged over 50% so far in 2025, could rally another 17% from here; while a likely mixed outlook for jewellery makers and sellers.

Indian Bank market-cap nears ₹1 trillion; stock zooms 43% in CY 2025

Indian Bank's market cap hit ₹99,655 crore in intra-day trade on the BSE. Meanwhile, analysts at Motilal Oswal Financial Services (MOFSL) reiterated BUY rating on Indian Bank stock.

September quarter set for GST hiccups, analysts back HUL, Britannia, Marico

Heavy rains in Q2FY26 adversely affected seasonal categories such as carbonated drinks, ready-to-drink juices, beer, ice creams, and hair/skin summer care products.

Has the GST reform-led stock market rally turned into a bull trap?

Data shows that over 50 per cent, or 255 stocks, from the Nifty 500 index had slipped below August 14 closing prices amid the over 3 per cent fall in Nifty 500 index from its recent high

Usha Martin surges 5%, hits new high; Axis Securities sees more upside

Technically, Usha Martin stock is trading well above its 20, 50, 100, and 200-day SMAs, reflecting robust underlying strength and a favourable trend structure, says Axis Securities in a note.

Stallion India soars 20%, hits new high; up 168% vs issue price in 8 months

Thus far in the month of September 2025, Stallion India Fluorochemicals has rallied 62 per cent, as compared to 0.77 per cent rise in the BSE Sensex.

TVS Electronics zooms 44% in 1 week; what's driving the smallcap stock?

In the past one month, the company engaged in computers hardware & equipments business has zoomed 70 per cent, as against 1 per cent gain in the BSE Sensex.

HPCL, BPCL, IOCL rally up to 4%; why OMC shares are in demand today?

Analysts believe that OMCs now have a large margin of safety owing to low oil price and a large capex plan which gives them confidence that a normative level of earnings will still be maintained.

Sammaan Capital soars 10% on heavy volumes, hits 7-month high; here's why

Till 09:41 AM, a combined 40.01 million equity shares representing 4.8 per cent of total equity of Sammaan Capital changed hands on the NSE and BSE.

Maruti Suzuki up 1%, hits new high in weak market; stock zooms 51% in 2025

Maruti stock hit a new high of ₹16,438.20 in intra-day trade today, and has outperformed the market by surging 11 per cent thus far in the month of September 2025.

Netweb Technologies zooms 69% in Sept; what's driving this smallcap stock?

Netweb Technologies stock hit a new high on Friday as the strong order book position is expected to boost the company's revenue and profits for the current and the coming financial year.

Nifty Pharma down 2.5% as Trump slaps 100% import tariffs; impact decoded

Among individual counters, Sun Pharma slumped 4.87 per cent to a fresh 52-week low of ₹1,548, while Gland Pharma tumbled 4.70 per cent to ₹1,880. Biocon declined 3.68 per cent to ₹342.85.

Titan gets Nomura 'Buy' call on strong jewellery market, 27% upside eyed

Analysts at Nomura have initiated coverage of Titan with a 'Buy' rating and a target price of ₹4,275, highlighting the company's strong positioning relative to peers on a risk-weighted basis.

L&T up 2%, outperforms market; here's why JM Financial sees more upside

In the past one month, L&T has outperformed the market and rallied 5 per cent, as compared to 0.1 per cent rise in the BSE Sensex.

BSE Smallcap index slips 2%; Symphony, Quess among 25 stocks at 52-week low

Thus far in the calendar year 2025, the BSE smallcap index has underperformed the market by falling 5%, as against 3% decline in midcap index and 3% rise in the BSE Sensex.

Dr Reddy's, Sun: Pharma stocks can crash up to 30% on Trump's 100% tariff

Indian pharma shares - Dr.Reddy's, Cipla, Sun, Lupin and Aurobindo Pharma stare at up to 30 downside risk hint technical charts as US President Donald Trump announces 100% tariff on pharma imports.